Phase 1b Study of Daratumumab plus Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (RRMM) with ≥2 Prior Lines of Therapy
- Resource Type
- Abstract
- Authors
- Chari, Ajai; Suvannasankha, Attaya; Fay, Joseph; Arnulf, Bertrand; Kaufman, Jonathan L.; Ifthikharuddin, Jainulabdeen; Weiss, Brendan M.; Krishnan, Amrita; Lentzsch, Suzanne; Comenzo, Ray; Wang, Jim; Masterson, Tara; Nottage, Kerri; Schecter, Jordan; Chiu, Christopher; Khokhar, Nushmia; Ahmadi, Tahamtan; Lonial, Sagar
- Source
- In Clinical Lymphoma Myeloma and Leukemia February 2017 17(1) Supplement:e14-e15
- Subject
- Language
- ISSN
- 2152-2650